Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. (Record no. 16912329)

MARC details
000 -LEADER
fixed length control field 01641 a2200457 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515061419.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200709s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1077-4114
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/MPH.0b013e3180335bcb
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Mitsiakos, George
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20070913
245 00 - TITLE STATEMENT
Title Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of pediatric hematology/oncology
Date of publication, distribution, etc. Mar 2007
300 ## - PHYSICAL DESCRIPTION
Extent 145-50 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Blood Coagulation Disorders
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Blood Coagulation Tests
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Administration Schedule
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug-Related Side Effects and Adverse Reactions
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Factor VII
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Factor VIIa
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Follow-Up Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hemorrhage
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infant, Newborn
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Maximum Tolerated Dose
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recombinant Proteins
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retrospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Papaioannou, Georgia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Giougi, Evagelia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Karagianni, Paraskevi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Garipidou, Vassilia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nikolaidis, Nikolaos
773 0# - HOST ITEM ENTRY
Title Journal of pediatric hematology/oncology
Related parts vol. 29
-- no. 3
-- p. 145-50
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1097/MPH.0b013e3180335bcb">https://doi.org/10.1097/MPH.0b013e3180335bcb</a>
Public note Available from publisher's website

No items available.